Form 4: Gabelli Healthcare & WellnessRx Trust: Director Mario J. Gabelli Increases Stake

Sentiment:

SEC Form 4 Filing


Mario J. Gabelli, a director and control person of the adviser for Gabelli Healthcare & WellnessRx Trust, has increased his holdings through direct and indirect purchases of common shares.

Summary

  • Mario J. Gabelli, a director and control person of the adviser for Gabelli Healthcare & WellnessRx Trust, has reported purchasing 4,000 common shares on December 30, 2024, at a price of $9.8 per share.
  • He also purchased an additional 2,000 common shares on December 31, 2024, at $9.7 per share.
  • Following these transactions, Mr. Gabelli directly owns 231,872 common shares.
  • Additionally, Mr. Gabelli indirectly owns 312,226 shares through GGCP, Inc., 8,000 shares through Associated Capital Group, Inc., 6,380 shares through GPJ Retirement Partners, and 2,000 shares through a trust account.
  • Mr. Gabelli disclaims beneficial ownership of the indirectly held shares exceeding his pecuniary interest in those entities.

Sentiment

Score: 6

Explanation: The document reflects a routine insider transaction. While the increased stake is positive, it's not a major event that would significantly alter the sentiment.

Positives

  • The director's purchase of shares indicates confidence in the company's prospects.
  • The increased stake by a key insider could be viewed positively by the market.

Industry Context

This filing is a routine disclosure of insider trading activity, which is common for publicly traded companies. It provides transparency into the actions of key personnel.

Comparison to Industry Standards

  • Insider trading disclosures are a standard practice for all publicly listed companies in the US.
  • The level of detail provided in this Form 4 is consistent with SEC requirements.
  • Similar filings are made by directors and officers of other investment trusts and publicly traded companies when they buy or sell shares.

Stakeholder Impact

  • The increased stake by a director may positively influence shareholder confidence.
  • The transactions do not have a direct impact on employees, customers, suppliers, or creditors.

Key Dates

DateDescription
12/30/2024Mario J. Gabelli purchased 4,000 common shares at $9.8 per share.
12/31/2024Mario J. Gabelli purchased 2,000 common shares at $9.7 per share.
01/02/2025Date of signature for the SEC Form 4 filing.

Keywords

Gabelli Healthcare & WellnessRx Trust, GRX, Mario J. Gabelli, insider trading, share purchase, beneficial ownership, common shares, director, GGCP, Inc., Associated Capital Group, Inc., GPJ Retirement Partners

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.